Sinohealth Holdings has been growing earnings at an average annual rate of 13%, while the Healthcare Services industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 8% per year. Sinohealth Holdings's return on equity is 14.1%, and it has net margins of 23.3%.
How Sinohealth Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
SEHK:2361 Revenue, expenses and earnings (CNY Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
30 Jun 24
411
96
89
63
31 Mar 24
403
99
87
62
31 Dec 23
396
102
85
61
30 Sep 23
388
101
83
60
30 Jun 23
380
100
81
59
31 Mar 23
369
78
81
60
31 Dec 22
357
56
80
60
30 Sep 22
348
61
76
59
30 Jun 22
338
66
71
58
31 Mar 22
331
72
71
56
31 Dec 21
324
79
71
54
31 Dec 20
202
68
32
40
31 Dec 19
178
56
24
29
Quality Earnings: 2361 has a high level of non-cash earnings.
Growing Profit Margin: 2361's current net profit margins (23.3%) are lower than last year (26.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2361's earnings have grown by 13% per year over the past 5 years.
Accelerating Growth: 2361's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 2361 had negative earnings growth (-3.9%) over the past year, making it difficult to compare to the Healthcare Services industry average (10.7%).
Return on Equity
High ROE: 2361's Return on Equity (14.1%) is considered low.
